BUX — BioMark Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual balance sheet for BioMark Diagnostics, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.02	0.612	0.878	0.383	0.072
Net Total Accounts Receivable
Net Total Receivables	0.013	0.016	0.027	0.082	0.034
Prepaid Expenses
Total Current Assets	0.033	0.628	0.923	0.499	0.126
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.009	0.027	0.969	0.589
Long Term Investments
Other Long Term Assets
Total Assets	0.035	0.637	0.953	1.47	0.732
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.25	1.08	0.922	1.5	1.66
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	1.25	1.08	1.03	2.11	1.88
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-1.22	-0.439	-0.079	-0.636	-1.15
Total Liabilities & Shareholders' Equity	0.035	0.637	0.953	1.47	0.732
Total Common Shares Outstanding